Corcept Therapeutics, Inc. (CORT)
32.15
-0.24
(-0.74%)
USD |
NASDAQ |
Mar 13, 16:00
32.17
+0.02
(+0.06%)
After-Hours: 20:00
Corcept Therapeutics Shareholders Equity (Quarterly) : 647.80M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | 88.30M |
| Alphatec Holdings, Inc. | 36.03M |
| Harrow, Inc. | 52.45M |
| Ultragenyx Pharmaceutical, Inc. | -80.00M |
| Amneal Pharmaceuticals, Inc. | -70.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 838.03M |
| Total Liabilities (Quarterly) | 190.22M |
| Debt to Equity Ratio | 0.0094 |
| Current Ratio | 2.892 |
| Net Debt Paydown Yield | 0.00% |